Papers
10
Total Citations
169
H-Index
8
About
Xavier Durand is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive robotic surgery for prostate and kidney cancers. His major contributions include pioneering the evaluation of the “Trifecta” outcome—the simultaneous achievement of continence, potency, and cancer control—after robotic-assisted laparoscopic extraperitoneal radical prostatectomy, a concept that has reshaped how surgical success is measured. His landmark 2011 study on this topic has garnered over 80 combined citations, establishing a benchmark for functional and oncologic outcomes. Durand has also been instrumental in comparing robotic partial nephrectomy with percutaneous ablation for elderly patients with T1 renal cell cancer, and in validating the Simplified PADUA Renal (SPARE) nephrometry scoring system to predict renal function after nephron-sparing surgery. His work on robot-assisted sacral colpopexy for urogenital prolapse further demonstrates his versatility. As a key contributor to the UroCCR collaborative network, Durand’s research—cited over 170 times—continues to guide clinical decision-making, emphasizing that the best surgical outcomes balance cancer control with quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10